Taking the lead: AnaptysBio Inc (ANAB)

With 0.55 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.95 million shares. The 52-week range on ANAB shows that it touched its highest point at $41.31 and its lowest point at $12.21 during that stretch. It currently has a 1-year price target of $34.36. Beta for the stock currently stands at 0.01.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ANAB was up-trending over the past week, with a rise of 58.46%, but this was up by 23.72% over a month. Three-month performance dropped to -2.78% while six-month performance fell -42.32%. The stock lost -13.84% in the past year, while it has gained 48.11% so far this year. A look at the trailing 12-month EPS for ANAB yields -6.07 with Next year EPS estimates of -5.32. For the next quarter, that number is -1.62. This implies an EPS growth rate of -0.07% for this year and 12.52% for next year. EPS is expected to grow by 6.04% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -19.45%.

Float and Shares Shorts:

At present, 30.43 million ANAB shares are outstanding with a float of 23.65 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ANAB since 6 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 3 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$5.70403 being high and -$6.2244 being low. For ANAB, this leads to a yearly average estimate of -$6.0843. Based on analyst estimates, the high estimate for the next quarter is -$1.08 and the low estimate is -$1.77. The average estimate for the next quarter is thus -$1.54.